Aspergillosis caused by non-fumigatus Aspergillus species: risk factors and in vitro susceptibility compared with Aspergillus fumigatus
- 26 February 2003
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 46 (1) , 25-28
- https://doi.org/10.1016/s0732-8893(03)00013-0
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Has Antifungal Susceptibility Testing Come of Age?Clinical Infectious Diseases, 2002
- Testing Conditions for Determination of Minimum Fungicidal Concentrations of New and Established Antifungal Agents for Aspergillus spp.: NCCLS Collaborative StudyJournal of Clinical Microbiology, 2002
- Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant RecipientsClinical Infectious Diseases, 2002
- Invasive Aspergillosis in 2002: An UpdateEuropean Journal of Clinical Microbiology & Infectious Diseases, 2002
- Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International ConsensusClinical Infectious Diseases, 2002
- Invasive Mold Infections in Allogeneic Bone Marrow Transplant RecipientsClinical Infectious Diseases, 2001
- Aspergillus terreus infections in haematological malignancies: molecular epidemiology suggests association with in-hospital plantsJournal of Hospital Infection, 2000
- In-vitro susceptibility of Aspergillus spp. isolates to amphotericin B and itraconazoleJournal of Antimicrobial Chemotherapy, 1999
- In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosisJournal of Antimicrobial Chemotherapy, 1998